Human Metabolome Technologies Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Human Metabolome Technologies Inc with three other
companies in this sector in Japan:
Medinet Co., Ltd.
sales of 998.28 million Japanese Yen [US$8.81 million]
PhoenixBio Co Ltd
(902.37 million Japanese Yen [US$7.97 million]
Gene Techno Science Co Ltd
(1.06 billion Japanese Yen [US$9.36 million]
of which 100%
was Drug Development).
Human Metabolome Technologies Inc reported sales of ¥938.18 million (US$8.28 million)
March of 2018.
increase of 2.6%
versus 2017, when the company's sales were ¥914.18 million.
Sales at Human Metabolome Technologies Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 89%).